You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
THE OFF-LABEL USE OF PSYCHOTROPIC MEDICINES IN PAEDIATRICS WITH MAJOR DEPRESSION
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Poster
- Poster code: POS-SAPS-039
- By: TANANA, Laila (University of Sydney, School of Pharmacy, Australia)
- Co-author(s): Laila Tanana: School of Pharmacy, University of Sydney, Australia
Asam Latif: School of Health Sciences, University of Nottingham, United Kingdom
Prasad S Nishtala: Department of Pharmacy & Pharmacology, University of Bath, United Kingdom
Timothy F Chen: School of Pharmacy, University of Sydney, Australia - Abstract:
Background
There is limited published research about the off-label use (OLU) of psychotropic medicines in paediatrics.Methods
The psychotropic medicines recommended by the Maudsley Guidelines for P-MD (≤18 years), were compared against the regulatory-approved SmPC (or equivalent) documents from Australia (AU), New Zealand (NZ), the United Kingdom.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026